Preventive effects of resveratrol against early-life impairments in the animal model of autism induced by valproic acid

Preventive effects of resveratrol against early-life impairments in the animal model of autism induced by valproic acid

Background: Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by social interaction deficits and repetitive/stereotyped behaviors. Its prevalence is increasing, affecting one in 36 children in the United States. The valproic acid (VPA) induced animal model of ASD is a re...

Full description

Bibliographic Details
Main Authors:	Gustavo Brum Schwingel, Mellanie Fontes-Dutra, Bárbara Ramos, Rudimar Riesgo, Victorio Bambini-Junior, Carmem Gottfried
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	IBRO Neuroscience Reports
Subjects:	Autism VPA Resveratrol Milestones Animal model Morphometric parameters
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123022650

Similar Items

Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autism
by: Júlio Santos-Terra, et al.
Published: (2022-04-01)

Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid
by: Mellanie Fontes-Dutra, et al.
Published: (2018-05-01)

Effects of Camel Milk on Antioxidant Activity in Rats with Valproic Acid-induced Autism
by: Sahar Heydari, et al.
Published: (2021-05-01)

Alterations of the Hippocampal Networks in Valproic Acid-Induced Rat Autism Model
by: Veronika Bódi, et al.
Published: (2022-02-01)

Acupuncture alters the intestinal microbiota in mice with valproic acid (VPA)-induced autism-like behavior
by: Zirong Bai, et al.
Published: (2022-12-01)

Beneficial effects of xenon inhalation on behavioral changes in a valproic acid-induced model of autism in rats
by: A. P. Dobrovolsky, et al.
Published: (2019-12-01)

Prenatal valproic acid-induced autism marmoset model exhibits higher salivary cortisol levels
by: Madoka Nakamura, et al.
Published: (2022-08-01)

Possible Mechanisms of the Neuroprotective Actions of Date Palm Fruits Aqueous Extracts against Valproic Acid-Induced Autism in Rats
by: Abdelaziz M. Hussein, et al.
Published: (2023-02-01)

Prenatal GABAB Receptor Agonist Administration Corrects the Inheritance of Autism-Like Core Behaviors in Offspring of Mice Prenatally Exposed to Valproic Acid
by: Shucai Jiang, et al.
Published: (2022-04-01)

The impact of neuroimmune alterations in autism spectrum disorder
by: Carmem eGottfried, et al.
Published: (2015-09-01)

Hippocampal neurons isolated from rats subjected to the valproic acid model mimic in vivo synaptic pattern: evidence of neuronal priming during early development in autism spectrum disorders
by: Marianela Evelyn Traetta, et al.
Published: (2021-03-01)

Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
by: Aoife M. Thornton, et al.
Published: (2021-06-01)

Data on social transmission of food preference in a model of autism induced by valproic acid and translational analysis of circulating microRNA
by: Mauro Mozael Hirsch, et al.
Published: (2018-06-01)

General developmental health in the VPA-rat model of autism
by: Monica Regina Favre, et al.
Published: (2013-07-01)

Analysis of variability of concentrations of valproic acid (VPA) and its selected metabolites in the blood serum of patients treated with VPA and patients hospitalized because of VPA poisoning
by: Jolanta Wilimowska, et al.
Published: (2015-03-01)

Valproic acid counteracts polycyclic aromatic hydrocarbons (PAHs)-induced tumorigenic effects by regulating the polarization of macrophages
by: Yisha Zhang, et al.
Published: (2022-08-01)

Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid.
by: Diego Baronio, et al.
Published: (2015-01-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

Carbapenems as Antidotes for the Management of Acute Valproic Acid Poisoning
by: Nataša Perković Vukčević, et al.
Published: (2024-02-01)

Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism
by: Claudia Cristiano, et al.
Published: (2022-01-01)

Oral Supplementation with Maca Improves Social Recognition Deficits in the Valproic Acid Animal Model of Autism Spectrum Disorder
by: Pinyue Fu, et al.
Published: (2023-02-01)

Tracking of Internal Granular Progenitors Responding to Valproic Acid in the Cerebellar Cortex of Infant Ferrets
by: Shiori Kamiya, et al.
Published: (2024-02-01)

Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder
by: Mingyang Zou, et al.
Published: (2021-02-01)

Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1
by: Jae Eun Lee, et al.
Published: (2015-12-01)

The Dual-Active Histamine H<sub>3</sub> Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice
by: Nermin Eissa, et al.
Published: (2020-06-01)

Valproate-coenzyme A conjugate blocks opening of receptor binding domains in the spike trimer of SARS-CoV-2 through an allosteric mechanism
by: Federica Maschietto, et al.
Published: (2023-01-01)

Valproic acid suppresses cuprizone-induced hippocampal demyelination and anxiety-like behavior by promoting cholesterol biosynthesis
by: Xinjian Zhu, et al.
Published: (2021-10-01)

Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid
by: Jade Marsh, et al.
Published: (2017-10-01)

Valproic Acid: A Promising Therapeutic Agent in Glioma Treatment
by: Wei Han, et al.
Published: (2021-09-01)

Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid
by: Alan Rubén Estrada-Pérez, et al.
Published: (2022-02-01)

Evaluation of the Effect of Valproic Acid on JAK/STAT Pathway, SOCS1, SOCS3, Bcl-xL, c-Myc, and Mcl-1 Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Human Colon Cancer HT29 Cell Line
by: M Sanaei Jahromi, et al.
Published: (2021-07-01)

SAMe, Choline, and Valproic Acid as Possible Epigenetic Drugs: Their Effects in Pregnancy with a Special Emphasis on Animal Studies
by: Asher Ornoy, et al.
Published: (2022-02-01)

Zebrafish Sexual Behavior in Plain and Enriched Environments: Parameters in the Valproate Model of Autism
by: Xiomara Velázquez-Landa, et al.
Published: (2023-03-01)

Iatrogenic Hypoglycemia Induced by Valproic Acid in an Adult Patient
by: Eugenia Rota, et al.
Published: (2021-04-01)

Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
by: Rita Barone, et al.
Published: (2021-06-01)

Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
by: Diego de Sá Coutinho, et al.
Published: (2018-06-01)

Intense World Theory: New Perspective in Brain\'s Function and the Role of Amygdala in Autism Spectrum Disorder
by: Shohreh Rahimian, et al.
Published: (2019-11-01)

Early developmental milestones in patients with idiopathic clubfoot treated by Ponseti method
by: Vito Pavone, et al.
Published: (2022-08-01)

Resveratrol in health and disease /
by: Aggarwal, Bharat B., 1950-, et al.
Published: (2006)

Prenatal S-Adenosine Methionine (SAMe) Induces Changes in Gene Expression in the Brain of Newborn Mice That Are Prevented by Co-Administration of Valproic Acid (VPA)
by: Liza Weinstein-Fudim, et al.
Published: (2020-04-01)